PGY-2 Pharmacy Residency Program

Montefiore Einstein’s postgraduate year two (PGY-2) Infectious Diseases (ID) Pharmacy Residency Program is a one-year program intended to build on the Doctor of Pharmacy education and postgraduate year one (PGY-1) pharmacy residency programs, building vital skills for clinical pharmacists across specialized practice areas.

PGY-2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge, and incorporating both into patient care.

Residents who successfully complete an accredited PGY-2 ID pharmacy residency are prepared for advanced patient care and academic or other specialized positions, along with board certification in infectious diseases (BCIDP).

The PGY-2 ID Pharmacy Residency Program is a 12-month structured training program with a focus on infectious diseases. The Program consists of core and elective learning experiences delivered longitudinally, in four-week blocks throughout the residency. 

PGY-2 residents will develop understanding and skills in infectious disease pharmacotherapy through participation in the Antimicrobial Stewardship Program and clinical activities with the Infectious Diseases consult services. 

PGY-2 residents will also engage in research and performance improvement projects. They will gain time management skills in adhering to a research timeline, creating an appropriate study design and methodology, completing data collection and analysis, submitting/presenting abstracts at national or regional conferences and publishing research findings.

In addition, residents will build on practice management and leadership skills through administrative functions. They’ll have multiple opportunities to precept and teach pharmacy residents and/or students and to participate in educational activities.

• Nationally recognized for clinical excellence (breaking new ground in research, training the next generation of healthcare leaders and delivering science-driven, patient-centered care)
• Ranked among the top hospitals nationally and regionally by U.S. News & World Report
• Premier academic medical center for Albert Einstein College of Medicine
• Centers of Excellence in cancer care, cardiovascular services, transplantation neuroscience and pediatric care
• Infectious Diseases Society of America (IDSA)-designated Center of Excellence for antimicrobial stewardship

111 East 20th Street, Bronx, NY 10467

While training at Moses Campus, PGY-2 infectious diseases pharmacy residents develop clinical expertise across medical, surgical and immunocompromised patient populations, including the care of solid organ transplant recipients and hematology-oncology and stem cell transplant patients. During a microbiology lab rotation, residents work with experts from the Clinical and Laboratory Standards Institute (CLSI), where they gain insight into the latest technology, methods of identification and susceptibility testing to assist antimicrobial stewardship interventions and optimize individualized antimicrobial pharmacotherapy. Residents also gain administrative experience through participating in the Antibiotic Subcommittee and our institution-wide Antimicrobial Stewardship Program.

1825 Eastchester Road, Bronx, NY 10461

At Jack D. Weiler Hospital, PGY-2 infectious diseases pharmacy residents use state-of-the-art/ clinical surveillance tools to perform therapeutic drug monitoring and antimicrobial stewardship interventions. Residents also engage in research and performance improvement projects as a part of their longitudinal learning experiences.

3415 Bainbridge Avenue, Bronx, NY 10467

While training at CHAM, our PGY-2 infectious diseases pharmacy residents gain experience in the treatment of a range of infections and develop a deep understanding of pediatrics, pharmacokinetics and pharmacodynamics.

6000 East 233rd Street, Bronx, NY 10466

Residents gain specialized experience.

Management of bone and joint infections, including prosthetic joint infections (PJI), osteomyelitis, and diabetic foot infections, with focus on optimizing antimicrobial therapy, PK/PD considerations, and multidisciplinary collaboration with Infectious Diseases, Orthopedic Surgery, and Microbiology teams.

Optimization of antimicrobial therapy in bone and joint infections, including prosthetic joint infections. This project will evaluate antibiotic selection, duration, and outcomes based on microbiologic etiology, surgical management strategy, and therapeutic drug monitoring data.

Applicants interested in the PGY-2 ID Pharmacy Residency Program at Montefiore Einstein should apply through the Pharmacy Online Residency Centralized Application Service (PhORCAS).

Applications must be submitted by the first Friday of January. Essential application information includes:

• Curriculum vitae
• Three letters of recommendation (LOR) submitted through PhORCAS
• A personal statement that describes goals and interests, motivation for completing a PGY-2 ID Pharmacy Residency and why the applicant wants to join Montefiore Einstein
• Official college of pharmacy transcript

Once application requirements are received and reviewed, the applicant will be considered for an interview. Montefiore Einstein recognizes that having a diverse and inclusive institution is critical to success, and we reaffirm our fervent commitment to fostering a culture in which diversity is a central tenet.